Table 5.
Treatment | n | ACE1 | ACE2 | AT1aR | AT1bR | AT2R | Mas1 |
---|---|---|---|---|---|---|---|
Vehicle | 5–7 | 1.0 ± 0.1 | 1.0 ± 0.2 | 1.0 ± 0.1 | 1.0 ± 0.2 | 1.0 ± 0.2 | 1.0 ± 0.1 |
Low-dose angiotensin II | 6–7 | 1.0 ± 0.0 | 2.4 ± 0.5* | 2.0 ± 0.2* | 1.5 ± 0.3 | 0.9 ± 0.2 | 2.0 ± 0.5* |
High-dose angiotensin II | 6 | 0.6 ± 0.1*# | 0.8 ± 0.1# | 4.3 ± 0.5*# | 1.3 ± 0.2 | 0.5 ± 0.0* | 1.2 ± 0.3 |
ACE: angiotensin converting enzyme; AT1aR: angiotensin type 1a receptor; AT1bR: angiotensin type 1b receptor; AT2R: angiotensin type 2 receptor.
Data are presented as fold increase in gene expression compared to vehicle-treated control group (2-∆∆Ct). All values are means ± SEM.
denotes P < 0.05 compared to vehicle-treated group, and
denotes P < 0.05 compared to low-dose treatment.